These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38567448)

  • 1. Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients.
    Ricklefs FL; Wollmann K; Salviano-Silva A; Drexler R; Maire CL; Kaul MG; Reimer R; Schüller U; Heinemann S; Kolbe K; Mummert T; Glatzel M; Peine S; Gempt J; Westphal M; Dührsen L; Lamszus K
    Neuro Oncol; 2024 Jul; 26(7):1280-1291. PubMed ID: 38567448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
    Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
    Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
    Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients.
    Osti D; Del Bene M; Rappa G; Santos M; Matafora V; Richichi C; Faletti S; Beznoussenko GV; Mironov A; Bachi A; Fornasari L; Bongetta D; Gaetani P; DiMeco F; Lorico A; Pelicci G
    Clin Cancer Res; 2019 Jan; 25(1):266-276. PubMed ID: 30287549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
    Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
    Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
    ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
    Rackles E; Lopez PH; Falcon-Perez JM
    Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic potential of extracellular vesicles in meningioma patients.
    Ricklefs FL; Maire CL; Wollmann K; Dührsen L; Fita KD; Sahm F; Herold-Mende C; von Deimling A; Kolbe K; Holz M; Bergmann L; Fuh MM; Schlüter H; Alawi M; Reimer R; Peine S; Glatzel M; Westphal M; Lamszus K
    Neuro Oncol; 2022 Dec; 24(12):2078-2090. PubMed ID: 35551407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Proof-Of-Principle Analysis Demonstrating Dielectrophoresis (DEP) as a Glioblastoma Biomarker Platform.
    Lewis J; Alattar AA; Akers J; Carter BS; Heller M; Chen CC
    Sci Rep; 2019 Jul; 9(1):10279. PubMed ID: 31311947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The von Willebrand factor stamps plasmatic extracellular vesicles from glioblastoma patients.
    Sabbagh Q; André-Grégoire G; Alves-Nicolau C; Dupont A; Bidère N; Jouglar E; Guével L; Frénel JS; Gavard J
    Sci Rep; 2021 Nov; 11(1):22792. PubMed ID: 34815502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma.
    Indira Chandran V; Welinder C; Månsson AS; Offer S; Freyhult E; Pernemalm M; Lund SM; Pedersen S; Lehtiö J; Marko-Varga G; Johansson MC; Englund E; Sundgren PC; Belting M
    Clin Cancer Res; 2019 May; 25(10):3115-3127. PubMed ID: 30679164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.
    Figueroa JM; Skog J; Akers J; Li H; Komotar R; Jensen R; Ringel F; Yang I; Kalkanis S; Thompson R; LoGuidice L; Berghoff E; Parsa A; Liau L; Curry W; Cahill D; Bettegowda C; Lang FF; Chiocca EA; Henson J; Kim R; Breakefield X; Chen C; Messer K; Hochberg F; Carter BS
    Neuro Oncol; 2017 Oct; 19(11):1494-1502. PubMed ID: 28453784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of STEAP1 extracellular vesicles in prostate cancer.
    Khanna K; Salmond N; Lynn KS; Leong HS; Williams KC
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):802-811. PubMed ID: 33589770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
    Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
    Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesiclemia: counting on extracellular vesicles for glioblastoma patients.
    Sabbagh Q; Andre-Gregoire G; Guevel L; Gavard J
    Oncogene; 2020 Sep; 39(38):6043-6052. PubMed ID: 32801336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
    Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools.
    Cela I; Capone E; Trevisi G; Sala G
    Semin Cancer Biol; 2024 Jun; 101():25-43. PubMed ID: 38754752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.